+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

NFATC1

Catalog No Product Description CAS No. Purity Structural Formula
BP0142
Alliin
Alliin is an L-alanine derivative in which one of the methyl hydrogens of L-alanine has been replaced by an (S)-allylsulfinyl group. It has a role as an antioxidant, an antimicrobial agent, a neuroprotective agent, a plant metabolite and a cardioprotective agent. It is a sulfoxide, an olefinic compound, a L-cysteine derivative, a non-proteinogenic alpha-amino acid and a L-alanine derivative. It is a tautomer of an alliin zwitterion. Alliin has antiglycating potential , it offers protection against glucose or methyglyoxal induced glycation of superoxide dismutase, hence is expected to have therapeutic potential in the prevention of glycation-mediated diabetic complications. Alliin has anti-inflammatory activity, it protects against Lipopolysaccharides (LPS)-induced acute lung injury (ALI) by activating PPARγ, which subsequently inhibits LPS-induced NF-κB activation and inflammatory response; alliin has an inhibitory effect in osteoclasteogenesis with a dose-dependent manner via blocking the c-Fos-NFATc1 signaling pathway, it could be a potential therapeutic agent in the treatment of osteoporosis. Alliin and sabinene have detectable levels of antimicrobial activity. Alliin, Oral active sulfoxide compounds can be isolated from garlic, which have hypoglycemic, antioxidant, anti-inflammatory, and anti-tumor activities.
556-27-4 98% Alliin
BP0135
Alismoxide
Alismoxide shows an inhibitory effect on the contraction of isolated bladder smooth muscle induced by carbachol; it demonstrates cytostatic action in HeLa cells, revealing potential use in virostatic cocktails. Alismoxide has inhibitory effects on vascular contraction induced by high concentration of KCl; it also shows an inhibitory effect on the direct passive Arthus reaction (DPAR) in rats in the type III allergic model. Alismoxide is a natural compound.
87701-68-6 98% Alismoxide
BP1492
Pteryxin
(+)-Pteryxin has muscle-relaxant props, it also shows hepatoprotective and nitric oxide prodn. inhibitory activity.
13161-75-6 98% Pteryxin
BP0120
Aconine
Aconine is a diterpene alkaloid with formula C25H41NO9 that is isolated from several Aconitum species. It has a role as a xenobiotic, a NF-kappaB inhibitor, a plant metabolite and a human urinary metabolite. It is a diterpene alkaloid, a tertiary alcohol, a secondary alcohol, a bridged compound, a pentol, an organic heteropolycyclic compound, a polyether and a tertiary amino compound. It derives from a hydride of an aconitane. Aconine can inhibit RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression. Aconine can attenuate hepatic fat degeneration of rats with fatty liver induced by high-fat diet through decreasing TG,TC deposit in liver. Aconine inhibits NF - κ B activation induced by ligands of nuclear factor kappa B receptor activators.
509-20-6 98% Aconine
BP1036
Ophiopogonin D
Ophiopogonin D plays a protective role as an effective antioxidant in H2O2-induced endothelial injury, it can attenuate doxorubicin-induced autophagic cell death by relieving mitochondrial damage in vitro and in vivo, it can be therefore developed as a novel drug for the therapy of cardiovascular disorders. Ophiopogonin D and spicatoside A can increase mucin production and secretion, by directly acting on airway epithelial cells, they could be as expectorants in diverse inflammatory pulmonary diseases. Ophiopogonin D inhibits MCF-7 cell growth via the induction of cell cycle arrest at the G2/M phase.
945619-74-9 98% Ophiopogonin D
BP0465
Dehydroevodiamine hydrochloride
Dehydroevodiamine hydrochloride has novel anti-cholinesterase and antiamnesic activities, it inhibits acetylcholinesterase activity in a dose-dependent and non-competitive manner(IC50=37.8 microM); its potent antiamnesic effect is thought to be due to the combined effects of acetylcholinesterase inhibition and the known cerebral blood flow enhancement. Dehydroevodiamine hydrochloride (0.1-0.3 mg/kg iv) can increase the cerebral blood flow recorded from the surface of the supra-sylvian gyrus in anesthetized cats, suggest that it selectively increases cerebral blood flow.
111664-82-5 98% Dehydroevodiamine hydrochloride
BP1073
Peiminine
Peiminine has potent anti-inflammatory, anti-allergic, antitussive, and expectorant effects. It induces autophagic cell death thus represses colorectal carcinoma tumor growth. Peiminine can inhibit lung inflammation and pulmonary fibrosis in a rat model of bleomycin-induced lung injury, by reducing circulating IFN-γ levels and inhibiting signal transduction pathways involving TGF-β, CTGF, ERK1/2, NF-κB and FasL.
18059-10-4 98% Peiminine
BP0440 63775-96-2 Cyclosporin D
BP0957
Monocrotaline
Monocrotaline is a pyrrolizidine alkaloid.
315-22-0 98% Monocrotaline
BP1825 214125-04-9 98% Jasminoside B
BP3755
Tilianin
Tilianin has anti-inflammatory, antiatherogenic, antihypertensive and vasorelaxant activities, mediates relaxation and antihypertension mainly by an endothelium-dependent manner, probably due to NO release, and also through an endothelium-independent pathway by opening K+ channels. Tilianin inhibits the tumor necrotic factor-K (TNF-K)-induced expression of VCAM-1 by 74% and reduces TNF-K-induced activation of nuclear factor-UB in cultured human umbilical vein endothelial cells (HUVECs).
4291-60-5 98% Tilianin
BP0429
Cyanidin chloride
Cyanidin Chloride, the main phenolic antioxidant in the grape (Vitis vinifera), in particular in the liposomal forms, could be used for treatment of diabetes mellitus complications. It has a dual effect on RANKL-induced osteoclastogenesis, exhibits therapeutic potential in prevention of osteoclasts related bone disorders.
528-58-5 98% Cyanidin chloride
BPC0449 81426-14-4 8-Acetoxypinoresinol
BP1215
Rhoifolin
Rhoifolin possesses a variety of significant biological activities including antioxidant, anti-inflammatory, antimicrobial, hepatoprotective and anticancer effects, it may be beneficial for diabetic complications through its enhanced adiponectin secretion, tyrosine phosphorylation of insulin receptor-β and GLUT4 translocation. Rhoifolin has a radioprotective effect against radiation-induced decrease of blood platelets and cardiac biochemical lesions in whole body irradiated mice. Apigenin 7-O-neohesperidoside is an apigenin derivative having an alpha-(12)-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety attached to the 7-hydroxy group. It has a role as a metabolite. It is a neohesperidoside, a dihydroxyflavone and a glycosyloxyflavone. It is functionally related to an apigenin.
17306-46-6 98% Rhoifolin
BP3993
Skullcapflavone II
Scullcapflavone II is a tetramethoxyflavone that is flavone substituted by methoxy groups at positions 6, 7, 8 and 6' and hydroxy groups at positons 5 and 2' respectively. It has a role as an anti-asthmatic drug, an EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor and a plant metabolite. It is a dihydroxyflavone and a tetramethoxyflavone. It is functionally related to a flavone. Skullcapflavone II is a flavonoid derived from Scutellaria baicalensis, a widely used herbal medicine in anti-inflammatory and anticancer therapy in Korea. Skullcapflavone II may have therapeutic potential for the treatment of allergic asthma.
55084-08-7 98% Skullcapflavone II
BP5288
Eleutherin
Eleutherin is a member of p-quinones and a benzoisochromanequinone.
478-36-4 98% Eleutherin
BPF2036
Petunidin chloride
Petunidin chloride is an anthocyanidin chloride that has petunidin as the cationic component. It has a role as a metabolite. Petunidin chloride has antioxidant, and anti-carcinogenesis activities.
1429-30-7 98% Petunidin chloride
BPC0413 137760-53-3 12-O-Acetylrosmarinine
BP2308
4-O-Caffeoylquinic acid methyl ester
4-O-E-caffeoylquinic acid methyl ester is a quinic acid. It is functionally related to a 4-O-trans-caffeoylquinic acid.
123372-74-7 98% 4-O-Caffeoylquinic acid methyl ester
BP5047
Pterosin B
Pterosin B is a salt-inducible kinase 3 (Sik3) pathway inhibitor, it prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3. Pterosin B shows cytotoxicity against HL 60 cells (human leukemia) with the IC(50) value of 8.7 microg/mL. Pterosin B has multiple targets in gluconeogenic programs, including coenzyme Q in RORα-SRC2 signaling.
34175-96-7 98% Pterosin B